{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:41:02Z","timestamp":1785548462589,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81703009"],"award-info":[{"award-number":["81703009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81773218"],"award-info":[{"award-number":["81773218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNA (miRNA) is involved in the physiological and pathological processes of various malignancies. In this study, miRNA microarray analysis showed that miR-4634 levels in A549 cells increased significantly after everolimus (RAD001) treatment. Decreased expression of miR-4634 was also found in non-small-cell lung carcinoma (NSCLC) cell lines and patients\u2019 tumors by qPCR. Additionally, a combination of miR-4634 and RAD001 exerted synergistic antitumor efficacy by inhibiting cell proliferation, migration, and colony formation. High expression of miR-4634 was significantly more common in non-cancerous lung tissue than adenocarcinoma or squamous cell carcinoma tissue (72.8%, 45.7%, and 50.9%, respectively; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Furthermore, high expression of miR-4634 was found to be more frequent in patients without lymph node metastasis (<jats:italic>P<\/jats:italic>\u2009=\u20090.037) by in-situ hybridization. Importantly, through univariate and multivariate analysis, high miR-4634 expression was associated with better prognosis of NSCLC patients. In conclusion, miR-4634 may act as a tumor suppressor in NSCLC, and to augment the efficacy of RAD001, co-treatment of miR-4634 and RAD001 might be a potential mTOR-targeted cancer therapy strategy for NSCLC patients. High expression of miR-4634 could be an independent good prognostic biomarker for NSCLC.<\/jats:p>","DOI":"10.1038\/s41598-020-70157-0","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T10:03:35Z","timestamp":1596535415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Sile","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"70157_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.12916","volume":"10","author":"M Cao","year":"2019","unstructured":"Cao, M. & Chen, W. Epidemiology of lung cancer in China. Thorac. Cancer 10, 3\u20137. https:\/\/doi.org\/10.1111\/1759-7714.12916 (2019).","journal-title":"Thorac. Cancer"},{"key":"70157_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334. https:\/\/doi.org\/10.3322\/caac.21551 (2019).","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"70157_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1186\/s40880-019-0368-6","volume":"39","author":"RM Feng","year":"2019","unstructured":"Feng, R. M., Zong, Y. N., Cao, S. M. & Xu, R. H. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?. Cancer Commun. (Lond) 39(22), 2019. https:\/\/doi.org\/10.1186\/s40880-019-0368-6 (2019).","journal-title":"Cancer Commun. (Lond)"},{"key":"70157_CR4","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s00018-018-2877-x","volume":"75","author":"C Bica-Pop","year":"2018","unstructured":"Bica-Pop, C. et al. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol. Life Sci. 75, 3539\u20133551. https:\/\/doi.org\/10.1007\/s00018-018-2877-x (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"70157_CR5","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1002\/jcp.26543","volume":"233","author":"B Jin","year":"2018","unstructured":"Jin, B., Jin, H., Wu, H. B., Xu, J. J. & Li, B. Long non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to accelerate non-small cell lung cancer cells progression and metastasis. J. Cell. Physiol. 233, 7164\u20137172. https:\/\/doi.org\/10.1002\/jcp.26543 (2018).","journal-title":"J. Cell. Physiol."},{"key":"70157_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/1878-0261.12200","volume":"12","author":"Y Xiao","year":"2018","unstructured":"Xiao, Y. et al. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy. Mol. Oncol. 12, 883\u2013895. https:\/\/doi.org\/10.1002\/1878-0261.12200 (2018).","journal-title":"Mol. Oncol."},{"key":"70157_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jconrel.2019.07.006","volume":"308","author":"M Moro","year":"2019","unstructured":"Moro, M. et al. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models. J. Control Release 308, 44\u201356. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.006 (2019).","journal-title":"J. Control Release"},{"key":"70157_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/acs.molpharmaceut.8b00071","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. MiroRNA-188 acts as tumor suppressor in non-small-cell lung cancer by targeting MAP3K3. Mol. Pharm. 15, 1682\u20131689. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00071 (2018).","journal-title":"Mol. Pharm."},{"key":"70157_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00280-016-3130-7","volume":"79","author":"H Zang","year":"2017","unstructured":"Zang, H., Wang, W. & Fan, S. The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer. Cancer Chemother. Pharmacol. 79, 227\u2013231. https:\/\/doi.org\/10.1007\/s00280-016-3130-7 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"70157_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-017-0219-9","volume":"9","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer. Cell Death Dis. 9, 193. https:\/\/doi.org\/10.1038\/s41419-017-0219-9 (2018).","journal-title":"Cell Death Dis."},{"key":"70157_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14199","author":"A Khandelwal","year":"2019","unstructured":"Khandelwal, A. et al. Circulating microRNA-590-5p acts as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci. https:\/\/doi.org\/10.1111\/cas.14199 (2019).","journal-title":"Cancer Sci."},{"key":"70157_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1158\/0008-5472.CAN-17-2069","volume":"78","author":"D Bhagirath","year":"2018","unstructured":"Bhagirath, D. et al. microRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Res. 78, 1833\u20131844. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2069 (2018).","journal-title":"Cancer Res."},{"key":"70157_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.7150\/ijbs.33986","volume":"15","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Serum microRNA signature is capable of early diagnosis for non-small cell lung cancer. Int. J. Biol. Sci. 15, 1712\u20131722. https:\/\/doi.org\/10.7150\/ijbs.33986 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"70157_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"J Polivka Jr","year":"2014","unstructured":"Polivka, J. Jr. & Janku, F. Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway. Pharmacol. Ther. 142, 164\u2013175. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.004 (2014).","journal-title":"Pharmacol. Ther."},{"key":"70157_CR15","doi-asserted-by":"publisher","first-page":"19523","DOI":"10.1073\/pnas.1902397116","volume":"116","author":"L He","year":"2019","unstructured":"He, L. et al. Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin. Proc. Natl. Acad. Sci. USA 116, 19523\u201319529. https:\/\/doi.org\/10.1073\/pnas.1902397116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70157_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/1933719118799199","volume":"26","author":"P Yang","year":"2019","unstructured":"Yang, P. et al. Endometrial miR-543 is downregulated during the implantation window in women with endometriosis-related infertility. Reprod. Sci. 26, 900\u2013908. https:\/\/doi.org\/10.1177\/1933719118799199 (2019).","journal-title":"Reprod. Sci."},{"key":"70157_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2018.07.040","volume":"174","author":"MP Dragomir","year":"2018","unstructured":"Dragomir, M. P., Knutsen, E. & Calin, G. A. SnapShot: unconventional miRNA functions. Cell 174, 1038. https:\/\/doi.org\/10.1016\/j.cell.2018.07.040 (2018).","journal-title":"Cell"},{"key":"70157_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b03694","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Electrochemiluminescence-microscopy for microRNA imaging in single cancer cell combined with chemotherapy-photothermal therapy. Anal. Chem. https:\/\/doi.org\/10.1021\/acs.analchem.9b03694 (2019).","journal-title":"Anal. Chem."},{"key":"70157_CR19","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.7150\/thno.37556","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen, W. et al. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Theranostics 9, 5739\u20135754. https:\/\/doi.org\/10.7150\/thno.37556 (2019).","journal-title":"Theranostics"},{"key":"70157_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/gad.328955.119","author":"A Acharya","year":"2019","unstructured":"Acharya, A. et al. miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19. Genes Dev. https:\/\/doi.org\/10.1101\/gad.328955.119 (2019).","journal-title":"Genes Dev."},{"key":"70157_CR21","doi-asserted-by":"publisher","first-page":"42557","DOI":"10.18632\/oncotarget.6449","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis. Oncotarget 6, 42557\u201342568. https:\/\/doi.org\/10.18632\/oncotarget.6449 (2015).","journal-title":"Oncotarget"},{"key":"70157_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cas.12880","volume":"107","author":"A Shimomura","year":"2016","unstructured":"Shimomura, A. et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 107, 326\u2013334. https:\/\/doi.org\/10.1111\/cas.12880 (2016).","journal-title":"Cancer Sci."},{"key":"70157_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13104-018-3541-0","volume":"11","author":"MDR Banos-Lara","year":"2018","unstructured":"Banos-Lara, M. D. R., Zabaleta, J., Garai, J., Baddoo, M. & Guerrero-Plata, A. Comparative analysis of miRNA profile in human dendritic cells infected with respiratory syncytial virus and human metapneumovirus. BMC Res. Notes 11, 432. https:\/\/doi.org\/10.1186\/s13104-018-3541-0 (2018).","journal-title":"BMC Res. Notes"},{"key":"70157_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/science.2554494","volume":"246","author":"T Takahashi","year":"1989","unstructured":"Takahashi, T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491\u2013494. https:\/\/doi.org\/10.1126\/science.2554494 (1989).","journal-title":"Science"},{"key":"70157_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer, X. et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333\u2013334. https:\/\/doi.org\/10.1093\/bioinformatics\/18.2.333 (2002).","journal-title":"Bioinformatics"},{"key":"70157_CR26","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1158\/1535-7163.MCT-17-0058","volume":"16","author":"MA Orr-Asman","year":"2017","unstructured":"Orr-Asman, M. A. et al. mTOR kinase inhibition effectively decreases progression of a subset of neuroendocrine tumors that progress on rapalog therapy and delays cardiac impairment. Mol. Cancer Ther. 16, 2432\u20132441. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0058 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"70157_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41401-019-0215-y","volume":"40","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial-mesenchymal transition. Acta Pharmacol. Sin. 40, 1085\u20131094. https:\/\/doi.org\/10.1038\/s41401-019-0215-y (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"70157_CR28","doi-asserted-by":"publisher","first-page":"27787","DOI":"10.18632\/oncotarget.8497","volume":"7","author":"Q Wen","year":"2016","unstructured":"Wen, Q. et al. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway. Oncotarget 7, 27787\u201327801. https:\/\/doi.org\/10.18632\/oncotarget.8497 (2016).","journal-title":"Oncotarget"},{"key":"70157_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","volume":"1","author":"VS Rodrik-Outmezguine","year":"2011","unstructured":"Rodrik-Outmezguine, V. S. et al. mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. Cancer Discov. 1, 248\u2013259. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0085 (2011).","journal-title":"Cancer Discov."},{"key":"70157_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.taap.2017.07.006","volume":"330","author":"T Li","year":"2017","unstructured":"Li, T. et al. Novel Hsp90 inhibitor platycodin D disrupts Hsp90\/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor. Toxicol. Appl. Pharmacol. 330, 65\u201373. https:\/\/doi.org\/10.1016\/j.taap.2017.07.006 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"70157_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87. https:\/\/doi.org\/10.1186\/1756-9966-30-87 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"70157_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1096\/fj.08-111005","volume":"23","author":"ME Guicciardi","year":"2009","unstructured":"Guicciardi, M. E. & Gores, G. J. Life and death by death receptors. FASEB J. 23, 1625\u20131637. https:\/\/doi.org\/10.1096\/fj.08-111005 (2009).","journal-title":"FASEB J."},{"key":"70157_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A. & D\u2019Orazi, G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 8, 603\u2013619. https:\/\/doi.org\/10.18632\/aging.100934 (2016).","journal-title":"Aging (Albany NY)"},{"key":"70157_CR34","doi-asserted-by":"publisher","first-page":"8871","DOI":"10.1074\/jbc.AAC120.014436","volume":"295","author":"W Yao","year":"2020","unstructured":"Yao, W. et al. Correction: Expression of death receptor 4 is positively regulated by MEK\/ERK\/AP-1 signaling and suppressed upon MEK inhibition. J. Biol. Chem. 295, 8871. https:\/\/doi.org\/10.1074\/jbc.AAC120.014436 (2020).","journal-title":"J. Biol. Chem."},{"key":"70157_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife https:\/\/doi.org\/10.7554\/eLife.05005 (2015).","journal-title":"Elife"},{"key":"70157_CR36","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.7150\/thno.17665","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Suppression of beta-catenin nuclear translocation by CGP57380 decelerates poor progression and potentiates radiation-induced apoptosis in nasopharyngeal carcinoma. Theranostics 7, 2134\u20132149. https:\/\/doi.org\/10.7150\/thno.17665 (2017).","journal-title":"Theranostics"},{"key":"70157_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol. Cancer 18, 40. https:\/\/doi.org\/10.1186\/s12943-019-0959-5 (2019).","journal-title":"Mol. Cancer"},{"key":"70157_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.humpath.2016.09.039","volume":"61","author":"S Chu","year":"2017","unstructured":"Chu, S. et al. High expression of heat shock protein 10 correlates negatively with estrogen\/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma. Hum. Pathol. 61, 173\u2013180. https:\/\/doi.org\/10.1016\/j.humpath.2016.09.039 (2017).","journal-title":"Hum. Pathol."},{"key":"70157_CR39","doi-asserted-by":"publisher","first-page":"e0132190","DOI":"10.1371\/journal.pone.0132190","volume":"10","author":"Q Wen","year":"2015","unstructured":"Wen, Q. et al. Flot-2 expression correlates with EGFR levels and poor prognosis in surgically resected non-small cell lung cancer. PLoS ONE 10, e0132190. https:\/\/doi.org\/10.1371\/journal.pone.0132190 (2015).","journal-title":"PLoS ONE"},{"key":"70157_CR40","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.3892\/ol.2016.5290","volume":"12","author":"K Mou","year":"2016","unstructured":"Mou, K. et al. Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer. Oncol. Lett. 12, 4613\u20134617. https:\/\/doi.org\/10.3892\/ol.2016.5290 (2016).","journal-title":"Oncol. Lett."},{"key":"70157_CR41","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1002\/cam4.2579","volume":"8","author":"H Zheng","year":"2019","unstructured":"Zheng, H. et al. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection. Cancer Med. 8, 6894\u20136903. https:\/\/doi.org\/10.1002\/cam4.2579 (2019).","journal-title":"Cancer Med."},{"key":"70157_CR42","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3892\/or.2019.7355","volume":"42","author":"H Zheng","year":"2019","unstructured":"Zheng, H. et al. Expression of DR5 and cFLIP proteins as novel prognostic biomarkers for nonsmall cell lung cancer patients treated with surgical resection and chemotherapy. Oncol. Rep. 42, 2363\u20132370. https:\/\/doi.org\/10.3892\/or.2019.7355 (2019).","journal-title":"Oncol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70157-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:54:18Z","timestamp":1670338458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70157-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70157-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"1 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13079"}}